Name: AmerisourceBergen Corp. (NYSE:ABC) | Analysis of Revenues
Creator: Stock Analysis on Net

Analysis of Revenues

Revenues as Reported

Revenues as Reported

Download chart

AmerisourceBergen Corp., income statement, revenues

US$ in thousands

12 months ended:	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017
Human Health	207,284,444)	197,777,128)	182,171,487)	—)	—)	—)
Animal Health	4,815,758)	4,684,417)	4,216,462)	—)	—)	—)
U.S. Healthcare Solutions	212,100,202)	202,461,545)	186,387,949)	—)	—)	—)
Alliance Healthcare	21,890,402)	7,373,365)	—)	—)	—)	—)
Other Healthcare Solutions	4,601,271)	4,156,264)	3,508,106)	—)	—)	—)
International Healthcare Solutions	26,491,673)	11,529,629)	3,508,106)	—)	—)	—)
Intersegment eliminations	(4,869)	(2,331)	(2,129)	—)	—)	—)
Revenue	238,587,006)	213,988,843)	189,893,926)	—)	—)	—)

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

Total revenue demonstrated a consistent upward trajectory from September 30, 2020, through September 30, 2022. Aggregate revenue increased from approximately 189.9 billion USD in 2020 to 238.6 billion USD in 2022, representing sustained expansion of the top-line performance over the analyzed period.

Core Domestic Performance: Human Health and U.S. Healthcare Solutions remain the primary drivers of total revenue. Human Health revenue grew from 182.2 billion USD in 2020 to 207.3 billion USD in 2022. Similarly, U.S. Healthcare Solutions increased from 186.4 billion USD to 212.1 billion USD, indicating steady growth in the core domestic market.
International Growth and Diversification: A significant acceleration is observed within international operations. International Healthcare Solutions experienced rapid growth, rising from 3.5 billion USD in 2020 to 26.5 billion USD in 2022. This trend is heavily influenced by the performance of Alliance Healthcare, which grew from 7.4 billion USD in 2021 to 21.9 billion USD in 2022, signaling a major expansion of the company's global footprint.
Secondary Segment Trends: Animal Health and Other Healthcare Solutions exhibited modest but stable growth. Animal Health revenue rose from 4.2 billion USD in 2020 to 4.8 billion USD in 2022, while Other Healthcare Solutions increased from 3.5 billion USD to 4.6 billion USD over the same timeframe.
Intersegment Eliminations: Intersegment eliminations increased in absolute value from -2.1 million USD in 2020 to -4.9 million USD in 2022, which is consistent with the overall increase in scale and internal transactional activity across the various business segments.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?